E84.0 Cystic fibrosis with pulmonary manifestations

Name of the Condition

• Cystic Fibrosis with Pulmonary Manifestations (ICD-10 Code: E84.0)

Summary

Cystic fibrosis with pulmonary manifestations is a subtype of cystic fibrosis characterized by respiratory symptoms and complications. It involves the production of thick, sticky mucus that clogs airways, leading to chronic lung infections, inflammation, and progressive lung damage. This condition requires ongoing management to address respiratory symptoms and slow disease progression.

Causes

Cystic fibrosis with pulmonary manifestations is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which disrupts the regulation of salt and water movement in cells. These mutations result in defective CFTR protein function, leading to abnormal mucus production in the lungs. The disorder follows an autosomal recessive inheritance pattern, meaning an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.

Risk Factors

• Family history of cystic fibrosis.
• Being of Northern European descent (higher prevalence).
• Carrying one copy of the CFTR mutation (carrier status).

Symptoms

• Persistent cough with thick mucus.
• Frequent lung infections (e.g., pneumonia, bronchitis).
• Wheezing or shortness of breath.
• Poor weight gain or growth despite adequate nutrition.
• Greasy, bulky stools or difficulty with bowel movements.
• Salty-tasting skin.

Diagnosis

Diagnosis involves a combination of clinical evaluation, genetic testing for CFTR mutations, and pulmonary function tests to assess lung function. Sweat chloride testing, which measures salt levels in sweat, is a key diagnostic tool. Imaging studies, such as chest X-rays or CT scans, may be used to evaluate lung damage. Newborn screening programs often detect the condition early, allowing for timely intervention.

Treatment Options

Treatment focuses on managing respiratory symptoms and preventing complications. Airway clearance techniques, such as chest physiotherapy or inhaled medications, help loosen mucus. Antibiotics treat or prevent lung infections. Anti-inflammatory drugs reduce airway inflammation. Nutritional support, including enzyme supplements and high-calorie diets, addresses malabsorption. Lung transplantation may be considered in advanced cases.

Prognosis and Follow-Up

Prognosis varies depending on the severity of lung involvement and adherence to treatment. Regular follow-up with a multidisciplinary team, including pulmonologists, dietitians, and respiratory therapists, is essential. Lifelong monitoring of lung function, nutritional status, and infection risk is required to manage the condition effectively.

Complications

• Chronic lung infections (e.g., Pseudomonas aeruginosa).
• Bronchiectasis (permanent airway damage).
• Respiratory failure.
• Nutritional deficiencies (e.g., vitamin deficiencies, malnutrition).
• Diabetes (due to pancreatic involvement).

Lifestyle & Prevention

• Avoid smoke and other respiratory irritants.
• Practice good hand hygiene to reduce infection risk.
• Follow a high-calorie, high-fat diet with enzyme supplements.
• Engage in regular physical activity to support lung function.
• Stay up-to-date with vaccinations (e.g., flu, pneumococcal).

When to Seek Professional Help

Seek medical attention if experiencing:

• Worsening cough or increased mucus production.
• Fever or signs of lung infection (e.g., chills, chest pain).
• Shortness of breath or wheezing.
• Unexplained weight loss or poor appetite.
• Changes in bowel habits (e.g., persistent diarrhea or constipation).

Tips for Medical Coders

When coding for cystic fibrosis with pulmonary manifestations (E84.0), ensure documentation supports the presence of respiratory symptoms or complications. Verify that the diagnosis aligns with the specific subtype and that any associated conditions (e.g., pancreatic insufficiency) are coded separately if applicable. Confirm the use of the correct ICD-10-CM code and review clinical notes for clarity on manifestations to avoid miscoding.